Login / Signup

Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE-KIDS 1 trial.

Satheesh ChonatEarl FieldsHannah Q BaratzAmanda WattMira PochronSandy DixonMargaret TondaClark BrownDavid Archer
Published in: EJHaem (2024)
These findings suggest that voxelotor treatment is associated with reduced RBC sickling and haemolysis in children with SCD.
Keyphrases
  • red blood cell
  • young adults
  • randomized controlled trial
  • phase iii
  • smoking cessation